Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Codexis Inc (CDXS)

Codexis Inc (CDXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 406,076
  • Shares Outstanding, K 81,378
  • Annual Sales, $ 70,140 K
  • Annual Income, $ -76,240 K
  • EBIT $ -51 M
  • EBITDA $ -41 M
  • 60-Month Beta 2.15
  • Price/Sales 5.77
  • Price/Cash Flow N/A
  • Price/Book 5.51

Options Overview Details

View History
  • Implied Volatility 78.10% ( -8.93%)
  • Historical Volatility 68.05%
  • IV Percentile 33%
  • IV Rank 13.71%
  • IV High 530.11% on 04/29/24
  • IV Low 6.29% on 06/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 7
  • Volume Avg (30-Day) 122
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 2,251
  • Open Int (30-Day) 2,567

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.02
  • Number of Estimates 3
  • High Estimate 0.04
  • Low Estimate -0.11
  • Prior Year 0.02
  • Growth Rate Est. (year over year) -200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.56 +3.29%
on 12/02/24
6.08 -22.53%
on 12/11/24
+0.13 (+2.84%)
since 11/29/24
3-Month
2.89 +62.69%
on 10/25/24
6.08 -22.53%
on 12/11/24
+1.63 (+52.92%)
since 09/30/24
52-Week
2.53 +86.17%
on 02/06/24
6.08 -22.53%
on 12/11/24
+1.66 (+54.43%)
since 12/29/23

Most Recent Stories

More News
Codexis Announces New Employment Inducement Grants

CDXS : 4.71 (-5.61%)
Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference

CDXS : 4.71 (-5.61%)
Codexis Pioneers Enzymatic Synthesis for siRNA Therapeutics and Demonstrates Superior Performance of Engineered Ligases at TIDES Europe 2024

Codexis shares new data on its siRNA therapeutic synthesis methods and performance advantages of its engineered ligases.Quiver AI SummaryCodexis, Inc. has made significant advancements in its Enzyme Catalyzed...

CDXS : 4.71 (-5.61%)
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics

CDXS : 4.71 (-5.61%)
Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors

CDXS : 4.71 (-5.61%)
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics

CDXS : 4.71 (-5.61%)
Codexis Announces New Employment Inducement Grants

CDXS : 4.71 (-5.61%)
Codexis to Participate in Upcoming Healthcare Conferences

CDXS : 4.71 (-5.61%)
Codexis: Q3 Earnings Snapshot

Codexis: Q3 Earnings Snapshot

CDXS : 4.71 (-5.61%)
Codexis Reports Third Quarter 2024 Financial Results

CDXS : 4.71 (-5.61%)

Business Summary

Codexis is a leading protein engineering company that applies its proprietary CodeEvolver technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and...

See More

Key Turning Points

3rd Resistance Point 5.41
2nd Resistance Point 5.25
1st Resistance Point 5.12
Last Price 4.71
1st Support Level 4.83
2nd Support Level 4.67
3rd Support Level 4.54

See More

52-Week High 6.08
Fibonacci 61.8% 4.72
Last Price 4.71
Fibonacci 50% 4.30
Fibonacci 38.2% 3.89
52-Week Low 2.53

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar